{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:01:38Z","timestamp":1789898498502,"version":"4.0.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,20]]},"DOI":"10.7759\/cureus.116579","type":"journal-article","created":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:35:56Z","timestamp":1789896956000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes and Inflammatory Biomarker Changes After Intravenous Ketamine-Lidocaine Infusion in Refractory Neuropathic Pain: A Prospective Observational Pilot Study"],"prefix":"10.7759","author":[{"given":"Ivan","family":"Keser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slavenka","family":"Straus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Imamovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermin","family":"Ismic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anida","family":"Jamakosmanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinela","family":"Omic Salkic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Sotonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Mihalj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup NB","year":"2021","unstructured":"Finnerup NB, Kuner R, Jensen TS. Neuropathic pain: from mechanisms to treatment. Physiol Rev. 2021, 101:259-301. 10.1152\/physrev.00045.2019","journal-title":"Physiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"van Hecke O","year":"2014","unstructured":"van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014, 155:654-62. 10.1016\/j.pain.2013.11.013","journal-title":"Pain"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup NB","year":"2015","unstructured":"Finnerup NB, Attal N, Haroutounian S, et al.. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015, 14:162-73. 10.1016\/S1474-4422(14)70251-0","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000808","article-title":"Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists","volume":"43","author":"Cohen SP","year":"2018","unstructured":"Cohen SP, Bhatia A, Buvanendran A, et al.. Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018, 43:521-46. 10.1097\/AAP.0000000000000808","journal-title":"Reg Anesth Pain Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000001080","article-title":"Intravenous lidocaine in chronic neuropathic pain: a systematic review","volume":"38","author":"Lee JH","year":"2022","unstructured":"Lee JH, Koutalianos EP, Leimer EM, Bhullar RK, Argoff CE. Intravenous lidocaine in chronic neuropathic pain: a systematic review. Clin J Pain. 2022, 38:739-48. 10.1097\/AJP.0000000000001080","journal-title":"Clin J Pain"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2217\/pmt-2023-0037","article-title":"Simultaneous application of lidocaine and ketamine during ambulatory infusion therapy: a retrospective analysis","volume":"13","author":"Striebel J","year":"2023","unstructured":"Striebel J, Ruppen W, Schneider T. Simultaneous application of lidocaine and ketamine during ambulatory infusion therapy: a retrospective analysis. Pain Manag. 2023, 13:539-53. 10.2217\/pmt-2023-0037","journal-title":"Pain Manag"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12113772","article-title":"Systemic anti-inflammatory effects of intravenous lidocaine in surgical patients: a systematic review and meta-analysis","volume":"12","author":"Castro I","year":"2023","unstructured":"Castro I, Carvalho P, Vale N, Monjardino T, Mour\u00e3o J. Systemic anti-inflammatory effects of intravenous lidocaine in surgical patients: a systematic review and meta-analysis. J Clin Med. 2023, 12:10.3390\/jcm12113772","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211026426","article-title":"Ketamine's effect on inflammation and kynurenine pathway in depression: a systematic review","volume":"35","author":"Kopra E","year":"2021","unstructured":"Kopra E, Mondelli V, Pariante C, Nikkheslat N. Ketamine's effect on inflammation and kynurenine pathway in depression: a systematic review. J Psychopharmacol. 2021, 35:934-45. 10.1177\/02698811211026426","journal-title":"J Psychopharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.12.010","article-title":"Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)","volume":"114","author":"Bouhassira D","year":"2005","unstructured":"Bouhassira D, Attal N, Alchaar H, et al.. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005, 114:29-36. 10.1016\/j.pain.2004.12.010","journal-title":"Pain"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.37.4.378","article-title":"Studies with pain rating scales","volume":"37","author":"Downie WW","year":"1978","unstructured":"Downie WW, Leatham PA, Rhind VM, Wright V, Branco JA, Anderson JA. Studies with pain rating scales. Ann Rheum Dis. 1978, 37:378-81. 10.1136\/ard.37.4.378","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin RH","year":"2008","unstructured":"Dworkin RH, Turk DC, Wyrwich KW, et al.. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008, 9:105-21. 10.1016\/j.jpain.2007.09.005","journal-title":"J Pain"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S358070","article-title":"Efficacy and safety of ketamine in the treatment of neuropathic pain: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Guimar\u00e3es Pereira JE","year":"2022","unstructured":"Guimar\u00e3es Pereira JE, Ferreira Gomes Pereira L, Mercante Linhares R, Darcy Alves Bersot C, Aslanidis T, Ashmawi HA. Efficacy and safety of ketamine in the treatment of neuropathic pain: a systematic review and meta-analysis of randomized controlled trials. J Pain Res. 2022, 15:1011-37. 10.2147\/JPR.S358070","journal-title":"J Pain Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/ph17091165","article-title":"Use of ketamine in patients with multifactorial neuropathic pain: a systematic review and meta-analysis","volume":"17","author":"Bruna-Mejias A","year":"2024","unstructured":"Bruna-Mejias A, Baeza V, Gamboa J, et al.. Use of ketamine in patients with multifactorial neuropathic pain: a systematic review and meta-analysis. Pharmaceuticals (Basel). 2024, 17:10.3390\/ph17091165","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.20.2433","article-title":"Depression and pain comorbidity: a literature review","volume":"163","author":"Bair MJ","year":"2003","unstructured":"Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003, 163:2433-45. 10.1001\/archinte.163.20.2433","journal-title":"Arch Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate CA Jr","year":"2006","unstructured":"Zarate CA Jr, Singh JB, Carlson PJ, et al.. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006, 63:856-64. 10.1001\/archpsyc.63.8.856","journal-title":"Arch Gen Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/531083-clinical-outcomes-and-inflammatory-biomarker-changes-after-intravenous-ketamine-lidocaine-infusion-in-refractory-neuropathic-pain-a-prospective-observational-pilot-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:35:57Z","timestamp":1789896957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/531083-clinical-outcomes-and-inflammatory-biomarker-changes-after-intravenous-ketamine-lidocaine-infusion-in-refractory-neuropathic-pain-a-prospective-observational-pilot-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,20]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.116579","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,20]]}}}